Daily Archives: October 2, 2007

When Conflicts of Interest Threaten Scientific Integrity | Public Library of Science


The growing commercialization of scientific research has increasingly forced biomedical publishers to grapple with real and perceived conflicts of interest. Every scientist has a competing interest when it comes to getting published in a high-profile journal—a prestigious publication record brings … Continue reading

Posted in PLoS Medicine | Leave a comment

When Conflicts of Interest Threaten Scientific Integrity | Public Library of Science


The growing commercialization of scientific research has increasingly forced biomedical publishers to grapple with real and perceived conflicts of interest. Every scientist has a competing interest when it comes to getting published in a high-profile journal—a prestigious publication record brings … Continue reading

Posted in PLoS Medicine | Leave a comment

Cochrane Child Health Field


The Cochrane Child Health Field, whose tag line is “promoting best evidence in child health,” has announced that a trials register will shortly be available. The register will be a searchable database of over 30,000 pediatric RCTs and CCTs published … Continue reading

Posted in Colaboracion Cochrane, PLoS Medicine | Tagged , , , , | Leave a comment

Parálisis de Bell


  Bell’s Palsy: Diagnosis and Management JEFFREY D. TIEMSTRA, MD, AND NANDINI KHATKHATE, MD Bell’s palsy is a peripheral palsy of the facial nerve that results in unilateral facial weakness. Approximately 70 to 80 percent of patients will have their … Continue reading

Posted in General | Leave a comment

Medwatch: vinculo entre bifosfonatos y fibrilación auricular


Bisphosphonates marketed as Alendronate (Fosamax, Fosamax Plus D), Etidronate (Didronel), Ibandronate (Boniva), Pamidronate (Aredia), Risedronate (Actonel, Actonel W/Calcium), Tiludronate (Skelid), and Zoledronic acid (Reclast, Zometa) Audience: Geriatricians, gynecologists, orthopedic surgeons, other healthcare professionals, consumers [Posted 10/01/2007] FDA issued an early … Continue reading

Posted in Efectos Adversos | Leave a comment